Speaker Profile
Lee S. Simon

Lee S. Simon MD, FACP, FACR

Rheumatology, Internal Medicine
Cambridge, Massachusetts, United States of America

Connect with the speaker?

Dr. Lee S. Simon served as the FDA's Division Director of Analgesic, Anti-inflammatory, and Ophthalmologic Drug Products (2001-2003). He served on multiple FDA advisory committees and has extensive experience in drug development as a senior investigator for celecoxib in the US. Dr. Simon was a senior consultant to Pharmacia/Searle on COX-2 development and has served on consulting advisory boards for numerous other pharmaceutical companies. For 12 years, he worked as an NIH-funded investigator and he has served two terms on the Board of Directors of the American College of Rheumatology (ACR). Dr. Simon has also served as Chair of the International COX-2 Study Group as well as Chair of Education for the ACR and the National Arthritis Foundation. He served on the Steering Committee of the NIH Osteoarthritis Initiative and has been Chair of the biannual Innovative Therapies in Autoimmune Disease conference sponsored by the ACR, FDA, NIH, and Arthritis Foundation. Dr. Simon is on the editorial boards of multiple journals and has authored more than 110 original publications, reviews, and book chapters, and has edited several textbooks.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)